Comparative effect of colchicine and colchiceine on cytotoxicity and CYP gene expression in primary human hepatocytes

被引:23
作者
Dvorak, Z
Ulrichova, J
Pichard-Garcia, L
Modriansky, M
Maurel, P
机构
[1] Palacky Univ, Fac Med, Inst Med Chem & Biochem, Olomouc 77515, Czech Republic
[2] CNRS, INSERM, U128, F-34293 Montpellier, France
关键词
colchiceine; colchicine; cytotoxicity; cytochrome P450; human hepatocyte;
D O I
10.1016/S0887-2333(02)00004-8
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The aims of the present study were (1) to determine the cytotoxicity of colchiceine (EIN) in comparison with that of colchicine (COL); (2) to evaluate the effect of EIN on cytochrome P450 (CYP) expression and activity, Primary human hepatocytes were the model of choice for cytotoxicity and CYP expression experiments. LDH leakage and albumin secretion served as cytotoxicity parameters. EIN was less toxic than COL based on both parameters within the concentration range 1-100 mum. 10 mum concentration of EIN did not induce the expression of CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2E1 and CYP3A4 isoforms, which were evaluated at the levels of mRNAs, proteins and specific activities in culture. EIN in concentrations up to 200 Pm had no effect on marker activities of CYP1A2, 2C9, 2E1 and 3A4 in human liver microsomes. It was concluded that ElN in concentrations up to 10 muM is not cytotoxic in primary human hepatocytes as revealed by albumin secretion and LDH leakage. Possible drug-drug interactions of EIN due to effects on cytochromes P4501A2, 2C9, 2E1 and 3A4 isoforms are unlikely because inhibition/induction studies show any lack of such effects. As EIN was shown to have better antifibrotic properties than COL (European Journal of Clinical Investigation 1997, 2, 77), it can be used as a COL substitute with anticipated fewer side-effects. (C), 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:219 / 227
页数:9
相关论文
共 34 条
[1]   Colchicine: 1998 update [J].
Ben-Chetrit, E ;
Levy, M .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1998, 28 (01) :48-59
[2]   COLCHICINE AND ITS ANALOGS - RECENT FINDINGS [J].
BROSSI, A ;
YEH, HJC ;
CHRZANOWSKA, M ;
WOLFF, J ;
HAMEL, E ;
LIN, CM ;
QUIN, F ;
SUFFNESS, M ;
SILVERTON, J .
MEDICINAL RESEARCH REVIEWS, 1988, 8 (01) :77-94
[3]  
CHANG YH, 1975, J PHARMACOL EXP THER, V194, P159
[4]  
Crespi C L, 1998, Methods Mol Biol, V107, P129
[5]  
Dvorak Zdenek, 2000, Acta Universitatis Palackianae Olomucensis Facultatis Medicae, V143, P47
[6]   INHIBITION OF FAST AXONAL-TRANSPORT AND MICROTUBULE POLYMERIZATION INVITRO BY COLCHICINE AND COLCHICEINE [J].
EDSTROM, A ;
HANSON, M ;
WALLIN, M ;
CEDERHOLM, B .
ACTA PHYSIOLOGICA SCANDINAVICA, 1979, 107 (03) :233-237
[7]   SUBSTRATE-REGULATED, HORMONE-REGULATED, AND CAMP-REGULATED CYTOCHROME P450 DEGRADATION [J].
ELIASSON, E ;
JOHANSSON, I ;
INGELMANSUNDBERG, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (08) :3225-3229
[8]  
Gerbal-Chaloin S, 2001, DRUG METAB DISPOS, V29, P242
[9]   The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module [J].
Goodwin, B ;
Hodgson, E ;
Liddle, C .
MOLECULAR PHARMACOLOGY, 1999, 56 (06) :1329-1339
[10]   Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone [J].
Gorski, JC ;
Jones, DR ;
Wrighton, SA ;
Hall, SD .
XENOBIOTICA, 1997, 27 (03) :243-256